Covered recipient · General Payments record
EDWARD J SALOPEK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,903.19
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.92 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $77.36 | 4 |
| Abbott Laboratories | $71.62 | 4 |
| Lilly USA, LLC | $35.87 | 2 |
| Amgen Inc. | $31.85 | 2 |
| GlaxoSmithKline, LLC. | $30.92 | 2 |
| ABBVIE INC. | $24.12 | 1 |
| PFIZER INC. | $23.67 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.34 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073902 | CMS |
| Abbott Laboratories | $18.69 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073904 | CMS |
| Abbott Laboratories | $20.35 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073906 | CMS |
| Abbott Laboratories | $16.24 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125073908 | CMS |
| ABBVIE INC. | $24.12 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106007590 | CMS |
| Amgen Inc. | $16.18 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117372860 | CMS |
| Amgen Inc. | $15.67 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117372862 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.51 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101559658 | CMS |
| GlaxoSmithKline, LLC. | $17.02 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116473263 | CMS |
| GlaxoSmithKline, LLC. | $13.90 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116384442 | CMS |
| Lilly USA, LLC | $17.17 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136154230 | CMS |
| Lilly USA, LLC | $18.70 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134966859 | CMS |
| Novo Nordisk Inc | $18.03 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097715314 | CMS |
| Novo Nordisk Inc | $20.75 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097788559 | CMS |
| Novo Nordisk Inc | $20.00 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096593070 | CMS |
| Novo Nordisk Inc | $18.58 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599089 | CMS |
| PFIZER INC. | $23.67 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131151992 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.